125 related articles for article (PubMed ID: 34774844)
21. Selective substrates for non-neuronal monoamine transporters.
Gründemann D; Liebich G; Kiefer N; Köster S; Schömig E
Mol Pharmacol; 1999 Jul; 56(1):1-10. PubMed ID: 10385678
[TBL] [Abstract][Full Text] [Related]
22. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1).
Strobel J; Müller F; Zolk O; Endreß B; König J; Fromm MF; Maas R
Amino Acids; 2013 Oct; 45(4):989-1002. PubMed ID: 23864433
[TBL] [Abstract][Full Text] [Related]
23. Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2.
Harper JN; Wright SH
Am J Physiol Renal Physiol; 2013 Jan; 304(1):F56-67. PubMed ID: 23034939
[TBL] [Abstract][Full Text] [Related]
24. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
Nishizawa K; Yoda N; Morokado F; Komori H; Nakanishi T; Tamai I
PLoS One; 2019; 14(4):e0214862. PubMed ID: 30951542
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes.
Okuda M; Urakami Y; Saito H; Inui K
Biochim Biophys Acta; 1999 Mar; 1417(2):224-31. PubMed ID: 10082798
[TBL] [Abstract][Full Text] [Related]
26. Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells.
Wongwan T; Chatsudthipong V; Soodvilai S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846898
[TBL] [Abstract][Full Text] [Related]
27. Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine.
Meyer MJ; Seitz T; Brockmöller J; Tzvetkov MV
PLoS One; 2017; 12(12):e0189521. PubMed ID: 29236753
[TBL] [Abstract][Full Text] [Related]
28. Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser.
Zolk O; Solbach TF; König J; Fromm MF
Drug Metab Dispos; 2009 Jun; 37(6):1312-8. PubMed ID: 19251820
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory Effect of Crizotinib on Creatinine Uptake by Renal Secretory Transporter OCT2.
Arakawa H; Omote S; Tamai I
J Pharm Sci; 2017 Sep; 106(9):2899-2903. PubMed ID: 28336299
[TBL] [Abstract][Full Text] [Related]
30. Irinotecan Alters the Disposition of Morphine Via Inhibition of Organic Cation Transporter 1 (OCT1) and 2 (OCT2).
Zhu P; Ye Z; Guo D; Xiong Z; Huang S; Guo J; Zhang W; Polli JE; Zhou H; Li Q; Shu Y
Pharm Res; 2018 Oct; 35(12):243. PubMed ID: 30361780
[TBL] [Abstract][Full Text] [Related]
31. Probing cholesterol binding and translocation in P-glycoprotein.
Thangapandian S; Kapoor K; Tajkhorshid E
Biochim Biophys Acta Biomembr; 2020 Jan; 1862(1):183090. PubMed ID: 31676371
[TBL] [Abstract][Full Text] [Related]
32. Biophysical Analysis to Assess the Interaction of CRAC and CARC Motif Peptides of Alpha Hemolysin of
Cané L; Guzmán F; Balatti G; Daza Millone MA; Pucci Molineris M; Maté S; Martini MF; Herlax V
Biochemistry; 2023 Jun; 62(12):1994-2011. PubMed ID: 37224476
[TBL] [Abstract][Full Text] [Related]
33. Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates.
Hacker K; Maas R; Kornhuber J; Fromm MF; Zolk O
PLoS One; 2015; 10(9):e0136451. PubMed ID: 26327616
[TBL] [Abstract][Full Text] [Related]
34. Substrate- and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd2+.
Thévenod F; Ciarimboli G; Leistner M; Wolff NA; Lee WK; Schatz I; Keller T; Al-Monajjed R; Gorboulev V; Koepsell H
Mol Pharm; 2013 Aug; 10(8):3045-56. PubMed ID: 23763587
[TBL] [Abstract][Full Text] [Related]
35. Drug-drug interaction between crizotinib and entecavir via renal secretory transporter OCT2.
Shu W; Ma L; Hu X; Zhang M; Chen W; Ma W; Huang J; Li J
Eur J Pharm Sci; 2020 Jan; 142():105153. PubMed ID: 31740393
[TBL] [Abstract][Full Text] [Related]
36. Key role of organic cation transporter 2 for the nephrotoxicity effect of triptolide in rheumatoid arthritis.
Shen Q; Wang J; Yuan Z; Jiang Z; Shu T; Xu D; He J; Zhang L; Huang X
Int Immunopharmacol; 2019 Dec; 77():105959. PubMed ID: 31644961
[TBL] [Abstract][Full Text] [Related]
37. Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates.
van der Velden M; Bilos A; van den Heuvel JJMW; Rijpma SR; Hurkmans EGE; Sauerwein RW; Russel FGM; Koenderink JB
Malar J; 2017 Oct; 16(1):422. PubMed ID: 29061131
[TBL] [Abstract][Full Text] [Related]
38. Organic cation transporter mRNA and function in the rat superior cervical ganglion.
Kristufek D; Rudorfer W; Pifl C; Huck S
J Physiol; 2002 Aug; 543(Pt 1):117-34. PubMed ID: 12181285
[TBL] [Abstract][Full Text] [Related]
39. Significance of Cholesterol-Binding Motifs in ABCA1, ABCG1, and SR-B1 Structure.
Dergunov AD; Savushkin EV; Dergunova LV; Litvinov DY
J Membr Biol; 2019 Feb; 252(1):41-60. PubMed ID: 30519876
[TBL] [Abstract][Full Text] [Related]
40. Mutations of the central tyrosines of putative cholesterol recognition amino acid consensus (CRAC) sequences modify folding, activity, and sterol-sensing of the human ABCG2 multidrug transporter.
Gál Z; Hegedüs C; Szakács G; Váradi A; Sarkadi B; Özvegy-Laczka C
Biochim Biophys Acta; 2015 Feb; 1848(2):477-87. PubMed ID: 25445676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
